What we know — and don’t know — about a new migraine drug
Aimovig was recently approved for use by the U.S. Food and Drug Administration
Migraines have plagued humans since time immemorial. Now a new migraine prevention treatment, recently approved by the U.S. Food and Drug Administration, promises long-awaited relief from the debilitating condition.
But whether the drug will turn out to be a real solution for the 1 in 7 Americans who suffer from migraines, severe headaches that often come with nausea and visual auras, isn’t yet clear.
Here’s what we know, and don’t know, about the new therapy.